Abstract:Investigating macrophage plasticity emerges as a promising strategy for promoting tissue regeneration and can be exploited by regulating the transient receptor potential vanilloid 4 (TRPV4) channel. The TRPV4 channel responds to various stimuli including mechanical, chemical, and selective pharmacological compounds. It is well documented that treating cells such as epithelial cells and fibroblasts with a TRPV4 agonist enhances the Ca2+ influx to the cells, which leads to secretion of pro-inflammatory cytokines, while a TRPV4 antagonist reduces both Ca2+ influx and pro-inflammatory cytokine secretion. In this work, we investigated the effect of selective TRPV4 modulator compounds on U937-differentiated macrophages encapsulated within three-dimensional (3D) matrices. Despite offering a more physiologically relevant model than 2D cultures, pharmacological treatment of macrophages within 3D collagen matrices is largely overlooked in the literature. In this study, pro-inflammatory macrophages were treated with an agonist, 500 nM of GSK1016790A (TRPV4(+)), and an antagonist, 10 mM of RN-1734 (TRPV4(−)), to elucidate the modulation of the TRPV4 channel at both cellular and extracellular levels. To evaluate macrophage phenotypic alterations within 3D collagen matrices following TRPV4 modulator treatment, we employed structural techniques (SEM, Masson's trichrome, and collagen hybridizing peptide (CHP) staining), quantitative morphological measures for phenotypic assessment, and genotypic methods such as quantitative real-time PCR (qRT-PCR) and immunohistochemistry (IHC). Our data reveal that pharmacological modulation of the macrophage TRPV4 channel alters the cytoskeletal structure of macrophages and influences the 3D structure encapsulating them. Moreover, we proved that treating macrophages with a TRPV4 agonist and antagonist enhances the expression of pro- and anti-inflammatory genes, respectively, leading to the upregulation of surface markers CD80 and CD206. In the TRPV4(−) group, the CD206 gene and CD206 surface marker were significantly upregulated by 9- and 2.5-fold, respectively, compared to the control group. These findings demonstrate that TRPV4 modulation can be utilized to shift macrophage phenotype within the 3D matrix toward a desired state. This is an innovative approach to addressing inflammation in musculoskeletal tissues.

TRPA1 activation and Hsp90 inhibition synergistically downregulate macrophage activation and inflammatory responses in vitro

Heat Shock Up-Regulates Expression Of Toll-Like Receptor-2 And Toll-Like Receptor-4 In Human Monocytes Via P38 Kinase Signal Pathway

TRPA1 Covalent Ligand JT010 Modifies T Lymphocyte Activation

Transient receptor potential ankyrin 1 contributes to the ATP-elicited oxidative stress and inflammation in THP-1-derived macrophage

TRPV4 facilitates the reprogramming of inflamed macrophages by regulating IL-10 production via CREB

Transient Receptor Potential Ankyrin 1 Channel Involved in Atherosclerosis and Macrophage-Foam Cell Formation

Anti-inflammatory activities of novel heat shock protein 90 isoform selective inhibitors in BV-2 microglial cells

Molecular basis of TRPA1 regulation in nociceptive neurons. A review

The TRPA1 ion channel is expressed in CD4+ T cells and restrains T-cell-mediated colitis through inhibition of TRPV1

Transient receptor potential vanilloid 1 interacts with TLR4/CD14 signaling pathway in lipopolysaccharide-mediated inflammation in macrophages

Inflammation—the role of TRPA1 channel

Mechanisms underlying TRPV4-mediated regulation of miR-146a expression

Disruption of Transient Receptor Potential Melastatin 2 Attenuate Lipopolysaccharide-Induced Heme Oxygenase-1 Expression in Mouse Macrophages Through P38 Mitogen-Activated Protein Kinase (P5202)

The vanilloid receptor TRPV1 is tonically activated in vivo and involved in body temperature regulation

TRPA1 Influences Staphylococcus Aureus Skin Infection in Mice and Associates with HIF-1a and MAPK Pathway Modulation

Presence of TRPA1 Modifies CD4+/CD8+ T Lymphocyte Ratio and Activation

Transient receptor potential ankyrin 1 (TRPA1) modulators: Recent update and future perspective

Activation of TRPA1 and TRPV1 in vagal nociceptive sensory neurons by inhibitors of mitochondrial function

TRPA1-Related Diseases and Applications of Nanotherapy

Modulating TRPV4 Channel Activity in Pro-Inflammatory Macrophages within the 3D Tissue Analog

Heat Shock Protein 90 is Critical for Regulation of Phenotype and Functional Activity of Human T Lymphocytes and NK Cells.